HB 1087 Indiana House · 2026 Regular Session

Overdose reversal medication.

Summary
Provides that, subject to available funding, the division of mental health and addiction may develop an application to provide funds to a school corporation or school maintained by a school corporation to obtain a federal Food and Drug Administration approved opioid overdose reversal medication. Provides that the state health commissioner shall issue a statewide standing order, prescription, or protocol for a federal Food and Drug Administration approved opioid overdose reversal medication for each public school or school corporation.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 5, 2026 Last action Jan 5, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
0
1 primary · 2 co-sponsors

Sponsors